WUGEN

Wugen is developing off-the-shelf cellular therapies for cancer. Our NK cell therapy products originate from healthy donors and are further manipulated in order to enhance their function to eliminate cancer cells. Our NK cell and CAR-T immuno-oncology therapies address the needs of patients with solid tumors, acute myeloid leukemia (AML) and T-cell malignancies.

#SimilarOrganizations #People #Financial #Website #More

WUGEN

Social Links:

Industry:

Biotechnology Therapeutics

Founded:

2018-01-01

Address:

St Louis, Missouri, United States

Country:

United States

Website Url:

http://www.wugen.com

Total Employee:

51+

Status:

Active

Total Funding:

172 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress

Similar Organizations

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.

Current Advisors List

peter-kiener_image

Peter Kiener Board Member @ Wugen
Board_member

bosun-hau_image

Bosun Hau Board Member @ Wugen
Board_member

bali-muralidhar_image

Bali Muralidhar Board Member @ Wugen
Board_member

john-mckearn_image

John McKearn Board Member @ Wugen
Board_member

Current Employees Featured

ayman-kabakibi_image

Ayman Kabakibi
Ayman Kabakibi Chief Operating Officer, Executive Vice President of Research & Development @ Wugen
Chief Operating Officer, Executive Vice President of Research & Development
2021-01-01

john-mckearn_image

John McKearn
John McKearn CHIEF EXECUTIVE OFFICER AND PRESIDENT @ Wugen
CHIEF EXECUTIVE OFFICER AND PRESIDENT

jan-davidson_image

Jan Davidson
Jan Davidson Chief Medical Officer @ Wugen
Chief Medical Officer
2021-02-01

not_available_image

Matthew Cooper
Matthew Cooper Co-Founder and Chief Scientific Officer @ Wugen
Co-Founder and Chief Scientific Officer
2018-08-01

Founder

not_available_image

Matthew Cooper

Investors List

intermediate-capital-group_image

Official Site Inspections

http://www.wugen.com Semrush global rank: 9.54 M Semrush visits lastest month: 141

Host Informations
Whois Informations

Loading ...